8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
People assigned to a diet, food or program and measured.
2019 / Randomized crossover trial
In a randomized crossover study, 24 healthy adult males consumed a high-fat breakfast with or without 50 g of freeze-dried mango pulp. At 1 hour post-meal, mango consumption resulted in significantly lower glucose (95.8 ± 4.4 mg/dL vs. 104.8 ± 5.4 mg/dL; P = .002) and higher HDL-C (58.4 ± 2.7 mg/dL vs. 55.2 ± 2.3 mg/dL; P = .01). However, no significant meal × time interactions were observed for triglycerides (P = .88), inflammatory markers (C-reactive protein, P = .17; interleukin-6, P = .30), or antioxidant enzymes (superoxide dismutase, P = .77; glutathione peroxidase, P = .36; catalase, P = .32).
O'Hara C, Ojo B, Emerson SR, et al. Nutr Metab Insights, 2019. PMID 31452602
2019 / Randomized crossover trial
In a randomized crossover trial of 30 females with elevated fasting glucose and insulin, consuming 250 g of baked then chilled potatoes reduced glucose at 15 and 30 minutes by 4.8% and 9.2%, insulin by 25.8% and 22.6%, and GIP by 41.1% and 37.6% compared to boiled potatoes. Insulin and GIP areas under the curve were significantly decreased. Glucose area under the curve, GLP-1, peptide YY, and satiety did not differ.
Patterson MA, Fong JN, Maiya M, et al. Nutrients, 2019. PMID 31484331
2019 / Case report
A 67-year-old female with type 2 diabetes and sepsis developed severe insulin resistance requiring >200 units of insulin per day in the ICU. She received a 2-day modified hypocaloric (700 kcal), low-fat, plant-based diet containing 180 g whole-grain oats and 60 g vegetables administered enterally. Glycaemic control improved significantly, and a significant reduction in total daily insulin requirements was observed during and after the intervention.
Storz MA, Helle P Complement Ther Med, 2019. PMID 31519290
2018 / Randomized crossover trial
In a randomized crossover trial with 13 healthy adults, adding two portions of cooked broccoli to mashed potato led to lower early postprandial blood glucose and insulin surges than potato alone. The broccoli-potato combination reduced peak glucose, incremental peak, and 30-minute incremental area under the curve for both markers. However, adding isolated broccoli fibre or cellulose did not alter post-meal curves compared with potato eaten by itself.
Ballance S, Knutsen SH, Fosvold ØW, et al. Eur J Nutr, 2018. PMID 27655525
2018 / Randomized controlled trial
A community pilot trial assigned 32 Latino adults with type 2 diabetes to a control group or an intervention receiving a 5-week education program on a high-fiber, low-fat plant-based diet plus periodic support. From baseline to 6 months, mean A1C fell from 9.57 to 9.49 in the control group and from 8.53 to 7.31 in the experimental group. The intervention group achieved a statistically significant A1C reduction compared to controls (P = .002).
Ramal E, Champlin A, Bahjri K Am J Health Promot, 2018. PMID 28503930
2018 / Randomized controlled pilot trial
Twenty-four obese male veterans were randomized to either a 5:2 intermittent energy-restricted diet or a standard daily energy-restricted diet for 6 months. Mean weight loss was 5.3 ± 3.0 kg (5.5 ± 3.2%) with the 5:2 diet and 5.5 ± 4.3 kg (5.4 ± 4.2%) with standard restriction, with no significant differences between groups for weight or waist reduction. Systolic blood pressure decreased in both groups, but neither regimen significantly shifted diastolic pressure, fasting glucose, or blood lipids.
Conley M, Le Fevre L, Haywood C, et al. Nutr Diet, 2018. PMID 28791787
2018 / Randomized crossover trial
During a three-day randomized crossover trial in 21 healthy participants, an isocaloric vegan diet lowered triglycerides, insulin, bile acids, and insulin resistance assessed by HOMA-IR (p < 0.05). It also raised magnesium levels and altered branched-chain amino acid metabolism compared with an omnivorous regimen. Fiber and polyunsaturated fats correlated inversely with triglycerides, insulin, and HOMA-IR.
Draper CF, Vassallo I, Di Cara A, et al. Mol Nutr Food Res, 2018. PMID 29087622
2018 / Randomized crossover trial
In a randomized crossover trial, 30 healthy individuals (15 with a family history of type 2 diabetes) consumed isocaloric high-cholesterol/high-fat (HChF) and low-cholesterol/low-fat (LChF) diets for 14 days each. Shifting from HChF to LChF had no effect on body weight but significantly reduced mean glucose (-5%, P = 0.01) and improved beta cell function, including glucose sensitivity (+17%, P = 0.01), fasting insulin secretion (+20%, P = 0.02), and potentiation (+19%, P = 0.03). Insulin sensitivity improved (+7%, P = 0.048) specifically in offspring of individuals with type 2 diabetes.
Tricò D, Trifirò S, Mengozzi A, et al. J Clin Endocrinol Metab, 2018. PMID 29095990
2018 / Randomized controlled dose-response crossover trial
In a randomized, controlled, dose-response crossover trial, 20 young, healthy Chinese men consumed isocaloric, macronutrient-matched test meals of white rice with three doses of curry made with mixed spices and vegetables. Plasma total GLP-1 concentrations were measured at baseline and for up to 3 hours postprandially. Total AUC of plasma GLP-1 concentrations, adjusted for baseline, increased in a dose-dependent manner: adjusted mean (±SEM) of 10568.3 ± 1267.9 pg ml-1.min for Dose 0 Control, 12391.8 ± 1333.94 pg ml-1.min for Dose 1 Curry, and 13905.1 ± 1267.6 pg ml-1.min for Dose 2 Curry (p = 0.019).
Haldar S, Chia SC, Henry CJ Eur J Clin Nutr, 2018. PMID 29284788
2018 / Randomized controlled trial
In an ancillary randomized controlled trial of 53 healthy nonobese adults, 24 months of caloric restriction decreased body weight by 9 ± 0.5 kg, visceral adipose tissue by 0.5 ± 0.01 kg, and blood pressure (systolic -8 ± 3 mmHg; diastolic -6 ± 2 mmHg) compared to ad libitum eating. Total cholesterol fell by 13.6 ± 5.3 mg/dl, LDL-cholesterol decreased by 12.9 ± 4.4 mg/dl, and estimated 10-year cardiovascular risk dropped by 30%. Insulin resistance initially improved during weight loss, but this change was not maintained during weight maintenance.
Most J, Gilmore LA, Smith SR, et al. Am J Physiol Endocrinol Metab, 2018. PMID 29351490
2018 / Randomized controlled trial
Thirty-seven adults with type 2 diabetes completed a 12-week trial testing two weekly very-low-calorie fasting days scheduled either consecutively (n=18) or non-consecutively (n=19). Fasting increased the risk of hypoglycaemia despite medication reduction (RR 2.05, 95% CI 1.17 to 3.52). However, hypoglycaemia rates did not differ significantly between consecutive and non-consecutive fasting regimens (RR 1.54, 95% CI 0.35 to 6.11).
Corley BT, Carroll RW, Hall RM, et al. Diabet Med, 2018. PMID 29405359
2018 / Open-label, non-randomized, controlled study
An open-label, non-randomized controlled study evaluated a 1-year continuous care intervention (CCI) delivering remote care, biometric feedback, and nutritional ketosis versus usual care (UC) in adults with type 2 diabetes. In the CCI group, HbA1c declined from 7.6 ± 0.09% to 6.3 ± 0.07%, weight decreased by 13.8 ± 0.71 kg, and non-metformin diabetes medication prescriptions fell from 56.9 ± 3.1% to 29.7 ± 3.0% (all P < 1.0 × 10^-16). Insulin was reduced or stopped in 94% of users, sulfonylureas were eliminated, and improvements were observed in HOMA-IR, hsCRP, and triglycerides, alongside a 10% increase in LDL-C; usual care participants had no significant biomarker or medication changes.
Hallberg SJ, McKenzie AL, Williams PT, et al. Diabetes Ther, 2018. PMID 29417495
2018 / Randomized trial
Twenty-seven overweight or obese adults were randomized to intermittent energy restriction (IER, n=15) or continuous energy restriction (CER) until achieving 5% weight loss, followed by 7 days of weight stabilization. There was no significant difference in time to 5% weight loss (median 59 d vs 73 d, P=0.246) or body composition changes between groups. Neither diet significantly altered postprandial glycaemia (P=0.266), and insulinaemia was reduced comparatively (P=0.903). However, IER led to a significantly greater relative reduction in postprandial TAG responses (106 to 68 mmol×360 min/l) compared to CER (117 to 130 mmol×360 min/l; P=0.045), and a trend toward a greater reduction in C-peptide (P=0.057).
Antoni R, Johnston KL, Collins AL, et al. Br J Nutr, 2018. PMID 29508693
2018 / Within-subject comparative study with washout
Ten patients with type 2 diabetes completed a 10-day supervised peri-operative-equivalent diet intervention, followed by a washout period, and then an identical diet paired with RYGB. Both interventions produced similar improvements in glucose levels, β-cell function, insulin sensitivity, and post-meal hepatic insulin resistance, alongside significant decreases in fasting and postprandial acyl ghrelin. The diet-only period led to greater improvements in basal hepatic glucose output and post-meal GIP secretion, whereas the diet plus RYGB intervention induced significantly greater increases in post-meal GLP-1, PYY, and glucagon levels.
Pop LM, Mari A, Zhao TJ, et al. Diabetes Obes Metab, 2018. PMID 29532631
2018 / Uncontrolled before-and-after intervention study
Participants in an outpatient cardiovascular clinic consumed a defined plant-based diet excluding all animal products and consisting of raw fruits, vegetables, seeds, and avocado for 4 weeks. Significant reductions were observed in systolic (-16.6 mmHg) and diastolic (-9.1 mmHg) blood pressure (P < 0.0005), serum lipids (P ≤ 0.008), and total medication usage (P < 0.0005). Reductions also occurred in weight (P < 0.0005), waist circumference (P < 0.0005), heart rate (P = 0.018), insulin (P < 0.0005), glycated hemoglobin (P = 0.002), and hs-CRP (P = 0.001).
Najjar RS, Moore CE, Montgomery BD Clin Cardiol, 2018. PMID 29575002
2018 / Randomized clinical study
A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.
Zhao L, Zhang F, Ding X, et al. Science, 2018. PMID 29590046
2018 / Crossover trial
Researchers evaluated the effect of a 45-minute aerobic exercise session performed either 17 hours prior (Prior Day Ex) or 40 minutes prior (Same Day Ex) versus no exercise on postprandial glucose control following a test meal in 11 normal weight and 12 overweight/obese adolescents. Across all trials, the overweight/obese group had higher fasting glucose (~6%) and insulin (~66%), and lower insulin sensitivity (~9%) than normal weight peers. Both Same Day Ex and Prior Day Ex reduced glucose area under the curve by 6% (P < .01), reduced insulin AUC by 15% and 13% respectively (P < .03), and increased insulin sensitivity by 8% and 6% respectively (P < .01). The magnitude of these effects did not differ between normal weight and overweight/obese groups.
Short KR, Pratt LV, Teague AM Pediatr Diabetes, 2018. PMID 29687558
2018 / Supervised controlled feeding randomized crossover trial
Researchers conducted a supervised controlled feeding trial to determine if intermittent fasting provides benefits independent of weight loss by feeding participants enough food to maintain weight. Men with prediabetes were randomized to early time-restricted feeding (a 6-hour feeding window with dinner before 3 p.m.) or a control schedule (12-hour feeding period) for 5 weeks, followed by crossover to the alternate schedule. Early time-restricted feeding improved insulin sensitivity, β cell responsiveness, blood pressure, oxidative stress, and appetite without weight loss.
Sutton EF, Beyl R, Early KS, et al. Cell Metab, 2018. PMID 29754952
2018 / Single-blinded randomized controlled trial
In a single-blinded randomized controlled trial, 53 constipated patients with type 2 diabetes received either 10 g of flaxseed pre-mixed in cookies twice daily or placebo cookies for 12 weeks. Compared with placebo, the flaxseed group showed statistically significant improvements in absolute change for constipation symptom scores (2.46 vs. 0.41), weight (-3.8 vs. 0.0 kg), BMI (-1.5 vs. -0.1 kg/m2), FPG (-26.7 vs. -1.9 mg/dl), HbA1c (-0.8 vs. 1.0%), cholesterol (-37.3 vs. -10.4 mg/dl), LDLC (-21.0 vs. -4.3 mg/dl), and HDLC (4.7 vs. -4.4 mg/dl; all P < 0.05). Compliance was reported as good, and no adverse effects were observed.
Soltanian N, Janghorbani M Nutr Metab (Lond), 2018. PMID 29760761
2018 / Randomized crossover trial
In a double-blind, multiple-crossover trial of 24 adults with type 2 diabetes, adding 10 g of allulose to a 75-g glucose drink significantly reduced plasma glucose incremental AUC by 8% (717.4 ± 38.3 vs. 777.5 ± 39.9 mmol × min/L, P = 0.015) with a linear dose response. Reductions also occurred for secondary glucose metrics at 5 g and 10 g. Fructose showed no effect at any tested dose.
Noronha JC, Braunstein CR, Glenn AJ, et al. Diabetes Obes Metab, 2018. PMID 29797503
2018 / Controlled feeding trial
In a controlled clinical trial, 38 overweight adults received 1,000 extra kcal per day from saturated fat, unsaturated fat, or simple sugars for 3 weeks. Intrahepatic triglyceride levels increased by 55% with saturated fat and by 15% with unsaturated fat (P < 0.05), compared to 33% with simple sugars. Saturated fat overfeeding also elevated lipolysis, insulin resistance, endotoxemia, and plasma ceramides.
Luukkonen PK, Sädevirta S, Zhou Y, et al. Diabetes Care, 2018. PMID 29844096
2018 / Intervention trial with matched historical controls
Obese participants (n = 23) adhered to an 8-h time-restricted feeding regimen (ad libitum feeding 10:00 to 18:00 h, water fasting 18:00 to 10:00 h) for 12 weeks, compared against 23 matched historical controls. Over 12 weeks, body weight decreased by -2.6% ± 0.5 and energy intake by -341 ± 53 kcal/d relative to controls (P < 0.05). Systolic blood pressure also fell (-7 ± 2 mm Hg vs controls, P < 0.05). Fat mass, lean mass, visceral fat mass, diastolic blood pressure, LDL cholesterol, HDL cholesterol, triglycerides, fasting glucose, fasting insulin, HOMA-IR, and homocysteine did not differ significantly between groups.
Gabel K, Hoddy KK, Haggerty N, et al. Nutr Healthy Aging, 2018. PMID 29951594
2018 / Randomized, placebo-controlled, double-blind parallel trial
Forty sedentary, obese men aged 40-70 years were randomized to receive 12 weeks of nicotinamide riboside (NR, 1000 mg twice daily) or placebo. NR supplementation did not improve insulin sensitivity, endogenous glucose production, glucose disposal, or glucose oxidation. Furthermore, NR had no effect on resting energy expenditure, lipolysis, lipid oxidation, or body composition. No serious adverse events occurred and safety blood tests remained normal.
Dollerup OL, Christensen B, Svart M, et al. Am J Clin Nutr, 2018. PMID 29992272
2018 / Randomized, placebo-controlled trial
Researchers randomly assigned 15,480 patients with diabetes and no evidence of atherosclerotic cardiovascular disease to receive daily 1-g capsules of n-3 fatty acids or an olive oil placebo. Over a mean follow-up of 7.4 years, serious vascular events occurred in 8.9% of the fatty acid group and 9.2% of the placebo group (rate ratio, 0.97; 95% CI, 0.87 to 1.08; P=0.55). The composite outcome of a serious vascular event or revascularization occurred in 11.4% and 11.5%, respectively (rate ratio, 1.00; 95% CI, 0.91 to 1.09), and all-cause death occurred in 9.7% versus 10.2% (rate ratio, 0.95; 95% CI, 0.86 to 1.05).
ASCEND Study Collaborative Group, Bowman L, Mafham M, et al. N Engl J Med, 2018. PMID 30146932